| P2093 | author name string | B Bonavida | |
| | J T Safrit | |
| P2860 | cites work | An endotoxin-induced serum factor that causes necrosis of tumors | Q24564406 |
| | A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF | Q28296638 |
| | Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism | Q33450431 |
| | Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin | Q34258651 |
| | Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity | Q36341041 |
| | Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes | Q36346529 |
| | Role of soluble cytotoxic factors in lymphokine-activated killer cell (LAK)-mediated cytotoxicity | Q39531883 |
| | Multistage model of natural killer cell-mediated cytotoxicity involving NKCF as soluble cytotoxic mediators | Q39676739 |
| | Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes | Q39733329 |
| | Cytolysis by H-2-specific T killer cells. Assembly of tubular complexes on target membranes | Q42936483 |
| | Immunologic control of ovarian cancer | Q44496284 |
| | Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor | Q46254405 |
| | Internucleosomal DNA cleavage precedes diphtheria toxin-induced cytolysis. Evidence that cell lysis is not a simple consequence of translation inhibition | Q46943728 |
| | Molecular cloning of the complementary DNA for human tumor necrosis factor | Q48379825 |
| | Vitamin E retards the lipoperoxidation resulting from anticancer drug administration | Q48807202 |
| | Studies on the mechanism of natural killer cell-mediated cytotoxicity. VII. functional comparison of human natural killer cytotoxic factors with recombinant lymphotoxin and tumor necrosis factor. | Q50903896 |
| | Tumor necrosis factor and IL-1 associated with plasma membranes of activated human monocytes lyse monokine-sensitive but not monokine-resistant tumor cells whereas viable activated monocytes lyse both. | Q52826705 |
| | Effects of tumor necrosis factor on sensitive and multidrug resistant human leukemia and myeloma cell lines. | Q54343312 |
| | Binding and crosslinking of 125I-labeled recombinant human tumor necrosis factor to cell surface receptors. | Q54423649 |
| | Reduction in glutathione content of L-PAM resistant L1210 Cells confers drug sensitivity. | Q54524063 |
| | Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1 | Q59066301 |
| | A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes | Q68804520 |
| | Cell-associated tumor necrosis factor (TNF) as a killing mechanism of activated cytotoxic macrophages | Q68812662 |
| | Target cell DNA fragmentation is mediated by lymphotoxin and tumor necrosis factor | Q68827742 |
| | Tumour cell killing by tumour necrosis factor: inhibition by anaerobic conditions, free-radical scavengers and inhibitors of arachidonate metabolism | Q69398620 |
| | Tumor necrosis factor and lymphotoxin secretion by human natural killer cells leads to antiviral cytotoxicity | Q69838877 |
| | DNA strand breaks, NAD metabolism, and programmed cell death | Q69994656 |
| | Differences in target cell DNA fragmentation induced by mouse cytotoxic T lymphocytes and natural killer cells | Q70010336 |
| | Activation of peritoneal lymphocyte cytotoxicity in patients with ovarian cancer by intraperitoneal treatment with Corynebacterium parvum | Q70797212 |
| P433 | issue | 5 | |
| P304 | page(s) | 321-328 | |
| P577 | publication date | 1992-01-01 | |
| P1433 | published in | Cancer Immunology, Immunotherapy | Q5031409 |
| P1476 | title | Hierarchy of in vitro sensitivity and resistance of tumor cells to cytotoxic effector cells, cytokines, drugs and toxins | |
| P478 | volume | 34 | |